Trials / Completed
CompletedNCT01949623
Biomarkers In Retinitis Pigmentosa (BIRP)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- Johns Hopkins University · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
In this study, markers of oxidative stress will be measured in the aqueous humour and plasma of RP patients compared to controls.
Detailed description
People with Retinitis Pigmentosa have loss of night vision followed by loss of central vision due to damage and death of photoreceptors. One of the mechanisms causing damage is high levels of oxygen in the eye. This damage produces specific biomarkers which can be measured. In this study, these biomarkers will be assessed in people with Retinitis Pigmentosa and compared to controls.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Anterior Chamber (AC) tap | Aqueous Samples will be collected for measurement of biomarkers |
Timeline
- Start date
- 2013-09-01
- Primary completion
- 2017-06-01
- Completion
- 2017-07-01
- First posted
- 2013-09-24
- Last updated
- 2017-08-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01949623. Inclusion in this directory is not an endorsement.